Pharma giant AstraZeneca announced plans to acquire FibroGen, Inc.’s China subsidiary for approximately $160 million. Expected to close mid-2025, the deal provides that FibroGen will receive an ...

Clint Eastwood, as well as Garrapatta LLC, filed a motion for default judgment Friday ...